Skip to main content

Rockwell Medical, Inc.

RMTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001041024

In the last 90 days, Rockwell Medical, Inc. insiders filed 0 open-market purchases and 1 sale; 37 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Rockwell Medical, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of RMTI: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders36360
Shares1.98M2.60M+613.0K (+30.9%)
Value$2.45M$3.32M+$875.8K (+35.8%)

New holders (6)

Institutions that held Rockwell Medical, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to RMTI in Q3 2022
InstitutionSharesValue% of portfolio
Jane Street Group, LLC21,053$28.0K0.00%
Two Sigma Securities, LLC13,997$18.0K0.00%
Wipfli Financial Advisors LLC,2,056$3.00K0.00%
FMR LLC1,353$2.00K0.00%
Barclays PLC2$00.00%
Royal Bank of Canada1$00.00%

Sold out (6)

Institutions that held Rockwell Medical, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of RMTI in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Price T Rowe Associates Inc17,462$23.0K
Nuveen Asset Management, LLC18,188$23.0K
Citadel Advisors LLC15,324$20.0K
Vectors Research Management, LLC1,134$1.00K
Baron Financial Group, LLC181$233
Northwestern Mutual Wealth Management Co35$0